Clinical Trial Update: IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for intramuscular and oral therapy in acute exacerbation of schizophrenia (BIZET Study) conducted by Pfizer/Mylan (Viatris) – comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED